Larry H Matherly Selected Research

Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)

1/2013	Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.
1/2011	A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
9/2009	RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.
2/2006	Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
2/2005	GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
2/2003	Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larry H Matherly Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 01/2003
8	Leukemia 02/2010 - 04/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 12/2010
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014 - 02/2004
6	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2013 - 02/2003
6	Down Syndrome (Down's Syndrome) 01/2013 - 02/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2012 - 02/2003
3	Ovarian Epithelial Carcinoma 01/2022 - 01/2017
3	Malignant Mesothelioma 01/2020 - 04/2013
3	Hereditary Folate Malabsorption 04/2014 - 01/2009
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2019
2	Mesothelioma 01/2020 - 12/2012
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2014 - 02/2010
2	Epilepsy (Aura) 12/2012 - 11/2010
2	Colorectal Neoplasms (Colorectal Cancer) 11/2009 - 02/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2022
1	Carcinogenesis 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Adenocarcinoma 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Inflammation (Inflammations) 03/2019
1	Adenocarcinoma of Lung 10/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2012
1	Breast Neoplasms (Breast Cancer) 04/2012

Drug/Important Bio-Agent (IBA)

28	Folic Acid AntagonistsIBA 01/2022 - 01/2003
24	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2008
22	Proton-Coupled Folate TransporterIBA 01/2021 - 01/2009
17	pyrimidineIBA 01/2022 - 10/2010
13	Reduced Folate Carrier ProteinIBA 01/2021 - 02/2004
12	purineIBA 01/2022 - 10/2010
11	Pemetrexed (MTA)FDA Link 01/2021 - 03/2007
10	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2004
10	Pharmaceutical PreparationsIBA 01/2020 - 01/2007
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2003
9	NucleotidesIBA 01/2022 - 12/2012
7	Hydroxymethyl and Formyl TransferasesIBA 01/2021 - 10/2011
7	glycinamide ribonucleotideIBA 01/2021 - 10/2011
6	CarbonIBA 12/2021 - 03/2019
5	EnzymesIBA 01/2021 - 01/2007
5	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 04/2002
5	Protons (Proton)IBA 10/2016 - 10/2010
5	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2012 - 02/2003
4	Biological ProductsIBA 05/2022 - 10/2010
4	SymportersIBA 10/2016 - 10/2010
4	Glutamic Acid (Glutamate)FDA Link 02/2012 - 08/2008
3	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 11/2020 - 10/2019
3	Folic Acid TransportersIBA 03/2019 - 03/2007
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2013 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2013
2	RibonucleotidesIBA 01/2021 - 01/2020
2	ThiophenesIBA 01/2021 - 02/2010
2	Adenosine Triphosphate (ATP)IBA 11/2020 - 10/2019
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2020 - 10/2019
2	PyrimidinesIBA 12/2019 - 05/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2018 - 04/2014
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2018 - 04/2014
2	TensinsIBA 08/2013 - 02/2010
2	Valproic Acid (Depakote)FDA LinkGeneric 12/2012 - 11/2010
2	Histone Deacetylase InhibitorsIBA 12/2012 - 11/2010
2	EstersIBA 10/2011 - 02/2010
2	Polyglutamic Acid (Polyglutamate)IBA 01/2008 - 03/2007
2	Arabinofuranosylcytosine TriphosphateIBA 02/2005 - 01/2004
2	Complementary DNA (cDNA)IBA 02/2005 - 08/2004
2	Cytidine DeaminaseIBA 02/2005 - 01/2004
1	ProteomeIBA 05/2022
1	CholesterolIBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	LipidsIBA 01/2022
1	N(alpha)- (4- amino- 4- deoxypteroyl)- N(delta)- hemiphthaloyl- L- ornithine (PT 523)IBA 01/2021
1	furanIBA 01/2021
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2020
1	CytosineIBA 04/2020
1	fluorocyclopentenylcytosineIBA 04/2020
1	Cadherins (E-Cadherin)IBA 04/2020
1	SulfurIBA 01/2020
1	Aligeron (AS 2)IBA 01/2020
1	Lactate Dehydrogenase 5IBA 01/2020
1	S 6 (S-6)IBA 01/2020
1	AmidesIBA 12/2019
1	NAD (NADH)IBA 10/2019
1	Propoxur (Baygon)IBA 09/2019
1	Chimeric Antigen ReceptorsIBA 03/2019
1	beta-Galactosidase (Lactaid)IBA 10/2018
1	FluorineIBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	10-propargyl-10-deazaaminopterin FDA Link 04/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2014
1	Notch1 ReceptorIBA 08/2013
1	Clofarabine (Clolar)FDA Link 12/2012
1	Purine NucleosidesIBA 12/2012
1	AminopterinIBA 09/2012
1	HhAntag691IBA 04/2012
1	Blood Proteins (Serum Proteins)IBA 04/2012
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 04/2012
1	AcidsIBA 02/2010

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 11/2020 - 12/2003
11	Therapeutics 01/2022 - 03/2007
1	Immunotherapy 10/2018